Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
We reviewed a retrospective series of 126 F-fluciclovine PET/CT studies of patients with biochemically recurrent prostate cancer at low (< 1 ng/mL) and very low (< 0.3 ng/mL) prostate-specific antigen (PSA) levels. The rate of PET/CT positivity was 33% (15/46) in patients with low PSA levels and 0% (0/17) in patients with very low PSA levels. Our results suggest that F-fluciclovine PET/CT can be helpful for localizing recurrence in patients with PSA levels between 0.3 and 1 ng/mL and that F-fluciclovine PET/CT is not recommended in patients with PSA levels less than 0.3 ng/mL.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2214/AJR.19.22180 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Super Responder of 177Lu-PSMA-617 PSMA Therapy in Patient With End-Stage Renal Disease on Hemodialysis.
Clin Nucl Med
September 2025
Department of Radiology and Nuclear Medicine, Comprehensive Cancer Care and Research Center (SQCCCRC), University Medical City, Muscat, Oman.
PSMA-targeted radioligand therapies with 177Lu-PSMA-617 have shown promising response rates with favorable toxicity in patients with metastasized castration-resistant prostate cancer. We report a case of a 72-year-old man with metastatic castration-resistant prostate cancer having comorbidities of DM, HTN, and end-stage renal disease (ESRD) on regular hemodialysis. The patient received 2 doses of 7.
View Article and Find Full Text PDFDissipation and dietary risk assessment of tetraniliprole, spirotetramat and its metabolites in brinjal and chilli under humid tropical conditions.
Food Addit Contam Part A Chem Anal Control Expo Risk Assess
September 2025
Department of Chemistry, CMS College, Mahatma Gandhi University, Kottayam, Kerala, India.
A single-laboratory ultra-performance liquid chromatography-mass spectrometry method was developed and validated for the estimation of tetraniliprole, BCS CQ 63359, spirotetramat and its metabolites from chilli and brinjal (commonly known as eggplant, aubergine or guinea squash) samples for assessing the dissipation kinetics and dietary risk assessment of field-applied tetraniliprole and spirotetramat. The control samples of brinjal and chilli fortified with tetraniliprole, spirotetramat and their metabolites at three levels of 0.01, 0.
View Article and Find Full Text PDFBiparametric vs Multiparametric MRI for Prostate Cancer Diagnosis: The PRIME Diagnostic Clinical Trial.
JAMA
September 2025
Division of Surgery and Interventional Science, UCL, London, United Kingdom.
Importance: Multiparametric magnetic resonance imaging (MRI), with or without prostate biopsy, has become the standard of care for diagnosing clinically significant prostate cancer. Resource capacity limits widespread adoption. Biparametric MRI, which omits the gadolinium contrast sequence, is a shorter and cheaper alternative offering time-saving capacity gains for health systems globally.
View Article and Find Full Text PDFPharmacist Peer-Led Teaching Enhances Medical Undergraduate Prescribing: A Mixed-Methods Study.
Clin Teach
October 2025
Warwick Medical School, Coventry, UK.
Background: Prescribing is a high-stakes clinical task where newly qualified doctors frequently report low confidence, with national data highlighting persistent error rates. Medical schools face logistical and staffing barriers in delivering high-quality, simulation-based prescribing education. Peer-led, interprofessional teaching, particularly by pharmacists, may offer a scalable solution in this context.
View Article and Find Full Text PDFFactors influencing the transition time from psoriasis to psoriatic arthritis: a real-world multicenter analysis.
Rheumatol Int
September 2025
Division of Rheumatology and Immunology, Department of PMR, , Sakarya University School of Medicine, Sakarya, Turkey.
To identify clinical and demographic predictors associated with the timing of transition from psoriasis (PsO) to psoriatic arthritis (PsA), and to compare the characteristics of patients with concurrent PsO-PsA onset versus those with prolonged transition. A multi-center, observational study was conducted using data from the Turkish League Against Rheumatism (TLAR) network including PsA patients fulfilling CASPAR criteria. Patients were categorized into two groups: Group 1 (concurrent PsO and PsA onset within ± 1 year) and Group 2 (prolonged transition to PsA, > 1 year after PsO).
View Article and Find Full Text PDF